Evaluating Targeted Therapeutic Response With Predictive Blood-Based Biomarkers in Patients With Chronic Mild Traumatic Brain Injury-Reference-Cited by-同舟云学术

Evaluating Targeted Therapeutic Response With Predictive Blood-Based Biomarkers in Patients With Chronic Mild Traumatic Brain Injury

Published:2023-06-01 Issue:1 Volume:4 Page:404-409
ISSN:2689-288X
Container-title:Neurotrauma Reports
language:en
Short-container-title:Neurotrauma Reports

Author:

Eagle Shawn R.¹,Puccio Ava M.¹,Agoston Denes V.²,Soose Ryan³,Mancinelli Michael¹,Nwafo Rachel¹,McIntyre Peyton¹,Agnone Allison¹,Tollefson Savannah¹,Collins Michael⁴,Kontos Anthony P.⁴,Schneider Walter⁵,Okonkwo David O.¹

Affiliation:

1. Department of Neurological Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.

2. School of Medicine, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.

3. Department of Otolaryngology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.

4. Department of Orthopaedic Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.

5. Department of Psychology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.

Publisher

Mary Ann Liebert Inc

Subject

Cellular and Molecular Neuroscience,Developmental Neuroscience

Link

https://www.liebertpub.com/doi/pdf/10.1089/neur.2023.0003

Reference24 articles.

1. Prevalence of Long-Term Disability From Traumatic Brain Injury in the Civilian Population of the United States, 2005

2. Incidence, Prevalence, Costs, and Impact on Disability of Common Conditions Requiring Rehabilitation in the United States: Stroke, Spinal Cord Injury, Traumatic Brain Injury, Multiple Sclerosis, Osteoarthritis, Rheumatoid Arthritis, Limb Loss, and Back Pain

3. Prognostic value of day-of-injury plasma GFAP and UCH-L1 concentrations for predicting functional recovery after traumatic brain injury in patients from the US TRACK-TBI cohort: an observational cohort study

4. Traumatic brain injury over the past 20 years: research and clinical progress

5. 5. FDA-NIH Biomarker Working Group. BEST (Biomarkers, EndpointS, and other Tools) Resource. U.S. Food and Drug Administration (Silver Spring, MD), National Institutes of Health (Bethesda, MD); 2016.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Maximizing the Clinical Value of Blood-Based Biomarkers for Mild Traumatic Brain Injury;Diagnostics;2023-10-28